KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4503.T
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Astellas Pharma Inc. stock price after Friday trading.
(Updated on Apr 26, 2024)

Hold candidate since Apr 26, 2024 PDF

The Astellas Pharma Inc. stock price gained 3.51% on the last trading day (Friday, 26th Apr 2024), rising from JP¥1,455.00 to JP¥1,506.00. During the last trading day the stock fluctuated 4.15% from a day low at JP¥1,446.00 to a day high of JP¥1,506.00. The price has been going up and down for this period, and there has been a -4.14% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 million more shares were traded than the day before. In total, 14 million shares were bought and sold for approximately JP¥20.43 billion.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.58% during the next 3 months and, with a 90% probability hold a price between JP¥1,267.60 and JP¥1,451.39 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4503.T Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 4.15%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Astellas Pharma Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at JP¥1,577.89. On a fall, the stock will find some support from the short-term average at JP¥1,477.64. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Astellas Pharma Inc. stock

Astellas Pharma Inc. finds support from accumulated volume at JP¥1,469.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved JP¥60.00 between high and low, or 4.15%. For the last week, the stock has had daily average volatility of 2.42%.

Our recommended stop-loss: JP¥1,425.17 (-5.37%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (4503.T) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Astellas Pharma Inc. to open at JP¥1,486.00, and during the day (based on 14 day Average True Range), to move between JP¥1,471.29 and JP¥1,540.71, which gives a possible trading interval of +/-JP¥34.71 (+/-2.30%) up or down from last closing price. If Astellas Pharma Inc. takes out the full calculated possible swing range there will be an estimated 4.61% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at JP¥1,469.00 (2.46%) than the resistance at JP¥1,575.50 (4.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Astellas Pharma Inc. stock A Buy?

Astellas Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.955 Hold/Accumulate Upgraded

Predicted Opening Price for Astellas Pharma Inc. of Tuesday, April 30, 2024

Fair opening price April 30, 2024 Current price
JP¥1,486.00 ( 1.33%) JP¥1,506.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4503.T

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1,546.00 2.66 %
R2 1,523.08 1.13 %
R1 1,508.92 0.194 %
Current price: 1,506.00
Support S1 1,463.08 -2.85 %
S2 1,448.92 -3.79 %
S3 1,426.00 -5.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1,636.00 8.63 %
R2 1,623.00 7.77 %
R1 1,575.50 4.61 %
Current price 1,506.00
Support S1 1,469.00 -2.46%
S2 1,451.50 -3.62%
S3 1,446.00 -3.98%

4503 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 27, 2024 Sep 27, 2024 Sep 27, 2024 JP¥0 0%
2 Mar 28, 2024 Mar 28, 2024 Mar 28, 2024 JP¥0 0%
3 Mar 30, 2023 Mar 30, 2023 Mar 30, 2023 JP¥30.00 1.60%
4 Sep 29, 2022 Sep 29, 2022 Sep 29, 2022 JP¥30.00 1.57%
5 Mar 30, 2022 Mar 30, 2022 Mar 30, 2022 JP¥25.00 1.28%

FAQ

What is the symbol for Astellas Pharma Inc. Stock and on which exchange is it traded?
The symbol for Astellas Pharma Inc. is 4503.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell Astellas Pharma Inc. Stock?
Astellas Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Astellas Pharma Inc. Stock?
Astellas Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Astellas Pharma Inc. Stock.

What's the current price of Astellas Pharma Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Astellas Pharma Inc. (4503.T) share was JP¥1,506.00.

What is the 52-week high and low for Astellas Pharma Inc. Stock?
The 52-week high for Astellas Pharma Inc. Stock is JP¥2,360.50 and the 52-week low is JP¥1,426.00.

What is the market capitalization of Astellas Pharma Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Astellas Pharma Inc. is 2.7T.

When is the next earnings date for Astellas Pharma Inc.?
The upcoming earnings date for Astellas Pharma Inc. is Jul 30, 2024.
Click to get the best stock tips daily for free!

About Astellas Pharma Inc.

Astellas Pharma. Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a ... 4503.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT